ADAR1 Capital Management »

Kezar Life Sciences shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Kezar Life Sciences (KZR) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Kezar Life Sciences

Tip: Access up to 7 years of quarterly data

All positions including Kezar Life Sciences held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kezar Life Sciences by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $213k 237k 0.90

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Kezar Life Sciences

Suvretta Capital Management
Avidity Partners Management
Tang Capital Management
Vanguard Group
Affinity Asset Advisors
Sphera Funds Management
OrbiMed Advisors
Acadian Asset Management
Stonepine Capital Management
Renaissance Technologies
Two Sigma Advisers
Acuitas Investments
Two Sigma Investments
Ikarian Capital
Goldman Sachs Group

View all funds holding Kezar Life Sciences